Burlingame, CA, United States of America

Tyto Life LLC


USPTO Granted Patents = 11

% Expired Patents = 18.2

Forward Citations = 171

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal John Hillerich Martin (5 out of 35 patents)

silverMedal Nicolas Pedro Lylyk (5 out of 283 patents)

bronzeMedal Don S Salerno (4 out of 9 patents)

4.  William Kip Speyer (3 out of 12 patents)

5.  Jonathan D Thielmann (3 out of 17 patents)

6.  Robby A Marsh (2 out of 11 patents)

7.  Samir Jadallah (1 out of 2 patents)

8.  Robert E Pruss (1 out of 7 patents)

9.  W Kip Speyer (1 out of 2 patents)

10.  Bryan D Dervarics (1 out of 2 patents)


11 patents:

Company Overview
Tyto Life LLC, based in Burlingame, California, specializes in the development of innovative telehealth solutions aimed at enhancing remote healthcare delivery. The company focuses on creating advanced medical devices that empower users to conduct health assessments from home, bridging the gap between patients and healthcare providers. By leveraging cutting-edge technology, Tyto Life aims to improve access to medical care and facilitate proactive health management, making healthcare more accessible and efficient for individuals and families.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#19 in Burlingame, CA

#6,541 in California

#27,514 in US

#51,761 in the World

Burlingame, CA (US)
Burlingame, CA, United States of America
Forward Citations = 171

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tyto Life LLC. Retrieved from https://idiyas.com/company/tyto-life

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…